fda safety communication semaglutide naion 2025 Semaglutide-associated risk of nonarteritic anterior ischemic optic neuropathy in patients with type 2 diabetes: A systematic review and meta-analysis of observational studies GLP-1 medicine and non-arteritic anterior

(PubMed) Zempleni J, Trusty TA, Mock DM

30 Specific concerns have been raised about eating-related fatalities, including choking on gorged food 32 and gastric necrosis and rupture following binging, particularly in slim but previously obese individuals

Fella Health is currently available in 20 states

Switching to iGlarLixi versus continuing daily or weekly GLP-1 RA in type 2 diabetes inadequately controlled by GLP-1 RA and oral antihyperglycemic therapy: the LixiLan-G Randomized Clinical Trial

At Cape Fear Physical Medicine and Rehab, were dedicated to helping you achieve a healthier lifestyle through evidence-based and patient-centered care